NCT05316935: GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 80 planned
- Started
- 13 Jul 2022
- Primary completion
- 30 Mar 2028
- Arms
- Non-obese EEC group (G), Non-obese EAH group (G)
- Results
- None posted
- 7 Apr 2022: Trial registered
- 13 Jul 2022: Trial started